mRNA |
BIBR-1532 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
mRNA |
MK-2206 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0008 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.17 |
0.001 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
KHS101 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.005 |
mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.006 |